Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3764041010 | Prednisolone (as prednisolone sodium phosphate) 15 mg orodispersible tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3764042015 | Product containing precisely prednisolone (as prednisolone sodium phosphate) 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
2641416015 | Prednisolone 15mg orally disintegrating tablet (product) | en | Fully specified name | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
2641416015 | Prednisolone 15mg orally disintegrating tablet (product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
2645513015 | Prednisolone 15mg orally disintegrating tablet | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
2645513015 | Prednisolone 15mg orally disintegrating tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3764041010 | Prednisolone (as prednisolone sodium phosphate) 15 mg orodispersible tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3764042015 | Product containing precisely prednisolone (as prednisolone sodium phosphate) 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely prednisolone (as prednisolone sodium phosphate) 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Is a | Prednisolone-containing product in oral dose form | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely prednisolone (as prednisolone sodium phosphate) 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Prednisolone | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely prednisolone (as prednisolone sodium phosphate) 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has manufactured dose form | Oral dose form | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely prednisolone (as prednisolone sodium phosphate) 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has manufactured dose form | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely prednisolone (as prednisolone sodium phosphate) 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has manufactured dose form | Conventional release oral tablet (dose form) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely prednisolone (as prednisolone sodium phosphate) 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely prednisolone (as prednisolone sodium phosphate) 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has manufactured dose form | Conventional release orodispersible tablet (dose form) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely prednisolone (as prednisolone sodium phosphate) 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has presentation strength denominator value | un | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely prednisolone (as prednisolone sodium phosphate) 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has presentation strength numerator unit (attribute) | mg | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely prednisolone (as prednisolone sodium phosphate) 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has basis of strength substance (attribute) | Prednisolone | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely prednisolone (as prednisolone sodium phosphate) 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely prednisolone (as prednisolone sodium phosphate) 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has precise active ingredient | Prednisolone sodium phosphate | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely prednisolone (as prednisolone sodium phosphate) 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely prednisolone (as prednisolone sodium phosphate) 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has presentation strength numerator value | 15 | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely prednisolone (as prednisolone sodium phosphate) 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Count of base of active ingredient | un | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely prednisolone (as prednisolone sodium phosphate) 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Is a | Prednisolone only product in oromucosal dose form | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely prednisolone (as prednisolone sodium phosphate) 15 milligram/1 each conventional release orodispersible tablet (clinical drug) | Is a | Prednisolone only product in oral dose form | true | Inferred relationship | Existential restriction modifier (core metadata concept) |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets